My Cart

Nucleocapsid protein

Nucleocapsid protein Overview

English NameNucleocapsid proteinsApproved Drugs0
Drugs in Clinical Trials2Target SynonymNucleocapsid Proteins
Highest Development StagePhase 2 Clinical
English NameNucleocapsid proteins
Target SynonymNucleocapsid Proteins
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

Nucleocapsid protein Background

The nucleocapsid (NP) protein of Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) is encoded by the S segment of its tripartite RNA genome. NP plays a central role in viral replication by encapsidating the genomic RNA and forming ribonucleoprotein complexes with the polymerase. It is highly conserved among SFTSV strains and strongly immunogenic, making it a major target for diagnostic assays and serological studies. Because of its abundance and stability, recombinant NP is widely used as an antigen for ELISA, rapid tests, and antibody development against this emerging tick-borne phlebovirus.

Nucleocapsid protein Synonyms

Nucleocapsid protein,NP,Protein N

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ZelicapavirEDP-938; EP-023938Phase 2 ClinicalEnanta Pharmaceuticals IncRespiratory Syncytial Virus Infections
Details
PF-07923567RV-299; PF-07923567Phase 1 ClinicalReviral LtdRespiratory Syncytial Virus Infections
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland